Please login to the form below

Not currently logged in
Email:
Password:

Results Healthcare appoints senior analyst

Carrie Yang will provide venture capital and business strategy experience

Result,-Carrie-Yang

London-based healthcare business strategist Results Healthcare has appointed Carrie Yang as a senior healthcare analyst.

She joins with seven years venture capital and business development experience in the life science, healthcare and TMT sectors, most recently with venture-funded startup, Cambridge Healthcare.

Over the course of her career she has also worked as an investment analyst in Shanghai, with Fidelity Asia Ventures; as a business analyst with financial services company ZLNX Consulting; and has also undertaken consulting work for GlaxoSmithKline and London-based biomarker solutions provider Abcodia.

"Carrie is a fantastic addition to the healthcare team, bringing broad experience in business analytics and business development," commented Results Healthcare managing director, Kevin Bottomley.

"Her skills augment and complement the extensive depth and breadth of knowledge across all aspects of the healthcare sector that we possess within the firm."

11th July 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...